Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Todd A. Swanson Image

      Todd A. Swanson, MD, PhD

      Department of Radiation Oncology, Division of Radiation Oncology

      About Dr. Todd A. Swanson

      Dr. Swanson has significant experience with Image Guided Radiation Therapy as well as High Dose Rate Brachytherapy. He specializes in the treatment of cancers of the lung, gastrointestinal tract, prostate, female reproductive tract and breast. He also works to coordinate clinical trials, as a member of the Radiation Therapy Oncology Group (RTOG). His work has been recognized with several awards from the American Society of Clinical Oncology and the American Brachytherapy Society. He attended the University of California- Davis, as an undergraduate majoring in Genetics and Political Science.

      After working in the laboratory focusing on molecular oncology at Genentech, he went on to pursue medical training at The Chicago Medical School. There, he completed both a Medical Degree (MD) and Doctor of Philosophy (PhD) in Microbiology and Immunology. He received his residency training at The William Beaumont Hospital in Royal Oak, MI where he served as chief resident. Now at UTMB, he strives to integrate cutting edge treatments with compassionate care in the comfort and cure of cancer patients.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      John J. Costanzi, MD Professorship in Oncology, Radiation Oncology, The University of Texas Medical Branch, Galveston, TX

      Education & Training

      Degree-Granting Education

      2005Rosalind Franklin University of Medicine and Science, Chicago, Illinois, US, MD
      2003Rosalind Franklin University of Medicine and Science, Chicago, Illinois, US, Doctorate of Philosophy, Ph.D
      1994University of California-Davis, Davis, California, US, Political Science, BAS

      Postgraduate Training

      2010-2012Clinical Fellowship, Hospice and Palliative Medicine, University of Texas Medical Branch, Galveston, Texas
      2006-2009Clinical Residency, William Beaumont Hospital, Royal Oak, Minnesota
      2005-2006Clinical Internship, William Beaumont Hospital, Royal Oak, Minnesota
      2003-2005Research Fellowship, Midwest Proteome Center, Chicago, Illinois

      Licenses & Certifications

      2024DEA
      2023Mississippi State Board of Medical Licensure
      2023Tennessee Board of Medical Examiners
      2023Goergia Composite Medical Board
      2023Oklahoma State Board of Medical Licensure
      2023Arizona Board of Medical Examiners
      2023Louisiana State Board of Medical Examiners
      2023Washingston State Department of Health
      2023Alabama Board of Medical Examiner
      2021Florida Board of Medicine
      2012American Board of Radiology Sub-specialty Certification in Hospice and Palliative Medicine
      2011Texas Medical Board
      2011American Board of Radiology Certification in Radiation Oncology
      2005Michigan State License

      Experience & Service

      Faculty Academic Appointments

      Professor, Radiation Oncology, The University of Texas Medical Branch, Galveston, TX, 2023 - 2025

      Associate Professor, Clinical Faculty Tract, Radiation Oncology, The University of Texas Medical Branch, Galveston, TX, 2021 - 2023

      Associate Professor, Clinical Faculty Tract, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Galveston, TX, 2021 - 2023

      Associate Professor, Term Tenure, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Galveston, TX, 2018 - 2021

      Associate Professor, Term Tenure, Radiation Oncology, The University of Texas Medical Branch, Galveston, TX, 2015 - 2021

      Assistant Professor, Radiation Oncology, The University of Texas Medical Branch, Galveston, TX, 2010 - 2015

      Administrative Appointments/Responsibilities

      Assistant Clinical Operations Lead, Radiation Oncology, The University of Texas Medical Branch, Galveston, TX, 2020 - Present

      Other Professional Positions

      CNS representative, The University of Texas MD Anderson Cancer Center, Houston, 2021 - Present

      CNS representative, The University of Texas MD Anderson Cancer Center, Houston, 2020 - Present

      Member, American Board of Radiology National In-service Exam Question Writer – GU Oncology, Galveston, TX, 2017 - Present

      Member, American Society for Radiation Oncology (ASTRO) Educational Committee, Galveston, TX, 2017 - Present

      Site Reviewer, American Society for Radiation Oncology (ASTRO) Accreditation Program for Excellence (APEx), Galveston, TX, 2017 - Present

      Reviewer Panel Member, Idea Development Awards and Synergistic Idea Development Awards, Congressionally Directed Medical Research Programs (CDMRP) Prostate Cancer Research Program (PCRP), Galveston, TX, 2017

      Founding Participant of Genitourinary Cancer Multidisciplinary Clinic, The University of Texas Medical Branch, Galveston, TX, 2016 - Present

      Founding Participant of Texas Department of Corrections Genitourinary Cancer Multidisciplinary Clinic, The University of Texas Medical Branch, Galveston, TX, 2016 - Present

      Reviewer Panel Member, Reviewer Panel Member for Idea Development Awards and Synergistic Idea Development Awards, CDMRP- PCRP, Galveston, TX, 2016

      UTMB Delegation Member, Chinese People’s Association for Friendship with Foreign Countries, Galveston, TX, 2015

      Reviewer Panel Member, Prostate Cancer Detection, Diagnosis and Prognosis Award, CDMRP- PCRP, Galveston, TX, 2015

      Site Reviewer, American College of Radiology (ACR) - Radiation Oncology Practice Accreditation, Galveston, TX, 2014 - 2017

      Reviewer Panel Member, Idea Development Awards and Synergistic Idea Development Awards, CDMRP- PCRP, Galveston, TX, 2013

      Radiobiology Researcher, William Beaumont Hospital, Chicago, IL, 2005 - 2010

      Teaching Assistant, Rosalind Franklin University of Medicine and Science, North Chicago, IL, 1999 - 2003

      Research Associate, Genetech, Inc, San Francisco, CA, 1994 - 1997

      Research Intern, Natural Products Chemistry Group, Novo Nordisk Entotech, Davis, CA, 1992 - 1994

      Extramural Institutional Committee Activities

      Member, Diversity, Equity, and Inclusion (DEI) Champion Program, The University of Texas MD Anderson Cancer Center, 2022 - 2023

      Safety and Quality Liaison, Radiation Oncology/Radiation Safety and Quality Program MDA/UTMB, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Institution Chairman, UTMB for the American College of Surgeons Commission on Cancer (COC), The University of Texas MD Anderson Cancer Center, 2017 - 2019

      Member, The University of Texas Medical School Curriculum Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Founding Moderator, UTMB Interdisciplinary Palliative Care Monthly Case Conference, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Member, UTMB Multidisciplinary Central Nervous System Tumor Board, The University of Texas MD Anderson Cancer Center, 2010 - Present

      Member, UTMB Multidisciplinary Gastrointestinal Tumor Board, The University of Texas MD Anderson Cancer Center, 2010 - Present

      Member, UTMB Multidisciplinary Thoracic Tumor Board, The University of Texas MD Anderson Cancer Center, 2010 - Present

      Member, UTMB Multidisciplinary Genitourinary Tumor Board, The University of Texas MD Anderson Cancer Center, 2010 - Present

      Member, UTMB Radiation Oncology Quality Assurance Committee, The University of Texas MD Anderson Cancer Center, 2010 - Present

      Editorial Activities

      Editorial Board, International Journal of Cancer and Oncology, 2014 - Present

      Editorial Board, American Journal of Biomedicine, 2014 - Present

      Honors & Awards

      2010ASCO Merit Award Recipient – Genitourinary Cancer Symposium, ASCO
      2010ASCO Merit Award Recipient – Molecular Markers in Cancer Symposium, ASCO
      2009ASCO Merit Award Recipient – Breast Cancer Symposium, ASCO
      2008Resident Travel Grant Award, American Brachytherapy Society
      2008Travel Grant Award, 10th Annual Lynn Sage Breast Cancer Symposium
      2000Chrysalis Travel Fellowship, American Academy of Allergy, Asthma
      1999Physician-Scientist Training Award $90,000 ($30,000/year) Immunology, American Diabetes Association

      Professional Memberships

      American Society of Therapeutic Radiology and Oncology (ASTRO)

      2008 - Present

      American Society of Clinical Oncology (ASCO)

      2008 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2023. Multidisciplinary Care Discussion Panel. Invited. Cancer Network Neuro-Oncology Integration Retreat. Houston, Texas, US.
      2. 2022. Radiation in the Management of Brain Metastasis. Invited. AIM at Melanoma Survivorship Symposium. Houston, Texas, US.

      National Presentations

      1. 2018. Optimizing the Management of cT2NO Disease: When is Chemoradiation Appropriate?. Invited. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      2. 2016. Evidence Based Approaches to Shortened Radiation Therapy Schedules for Patients in the Palliative Care Setting. Invited. 12th Annual Association of Veteran's Affairs Hematology/Oncology (AVAHO). Dallas, TX, US.
      3. 2014. Current modalities of accelerated partial breast irradiation. Invited. European School Oncology, US.
      4. 2013. Evidence Based Approaches to Shortened Radiation Therapy Schedules for Patients in the Palliative Care Setting. Invited. MD Anderson. Dallas, TX, US.
      5. 2013. Cost analysis of adjuvant management strategies in early-stage testicular seminoma. Conference. American Society for Clinical Oncology, Genitourinary Cancers Symposium, US.
      6. 2012. Scalp sparing whole brain radiation therapy: Is IMRT and IGRT required?. Conference. 94th Annual Meeting of the American Radium Society. (ABST# 40686),, US.
      7. 2012. Testicular Recovery in Patients with Intermediate and High Risk Prostate Cancer treated with Radiation Therapy and Androgen Deprivation Therapy, A Contemporary UTMB Experience. Conference. 91st Annual Meeting of the South Central Section of the American Urological Association, US.
      8. 2010. Effect of TMPRSS2/ERG fusion gene expression on radio and chemo-responsiveness in prostate cancer cell lines. Conference. . American Society for Clinical Oncology, Genitourinary Cancers Symposium,(ABST#16), US.
      9. 2009. Six Year Experience Routinely Utilizing Moderate Deep Inspiration Breath-Hold (mDIBH) for the Reduction of Cardiac Dose in Left Sided Breast Irradiation for Patients with Early Stage or Locally Advanced Breast Cancer. Conference. American Society for Therapeutic Radiology and Oncology 51st Annual Meeting, (ABST#107), US.
      10. 2009. TMPRSS2/ERG fusion gene expression alters radio-responsiveness in cell culture models of androgen independent prostate cancer. Conference. American Society for Therapeutic Radiology and Oncology 51st Annual Meeting, (ABST#39), US.
      11. 2007. Improved 10-year Outcomes for Prostate Cancer Patients With Gleason 8–10 Treated With Intensity Modulated High Dose Rate Brachytherapy Boost in the PSA Era. Conference. American Society for Therapeutic Radiology and Oncology, (ABST#148), 49th Annual Meeting, US.

      International Presentations

      1. 2025. Neuro-Oncology Track: Benign Brain Tumors. Panelist. 2025 Annual Neurotech Convention. Los Angeles, US.
      2. 2015. Stereotactic Body Radiotherapy in the Management of Lung Cancer. Invited, US.
      3. 2012. Case Studies in Accelerated Breast Irradiation. Invited. BIT's 5th World Cancer Congress (WCC), CN.
      4. 2008. Improved 10-year Outcomes for Prostate Cancer Patients with Gleason 7-10 Treated with High Dose Rate Brachytherapy Boost in the PSA era. Conference. World Congress of Brachytherapy, US.

      Formal Peers

      1. 2022. Radiation in the Management of Brain Metastasis. Invited. Houston, TX, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Mathews, N, Jaffe, A, McMichael, K, Redjal, N, Cardonick, E, Swanson, T, Kry, SF, Salacz, ME, Mann, JM. Magnetic Resonance Guided Radiation Therapy for High-Grade Glioma in Pregnancy. Advances in Radiation Oncology 11(10), 2026. e-Pub 2026. PMID: 42382437.
      2. Carriere PP, Haisraely O, Aaroe A, Ahmed K, Lewis R, Colson-Fearon D, Bolden M, Swanson TA, Beckham TH, Wang C, De B, Perni S, Tom MC, Li J, McGovern S, McAleer MF, Ghia A, Jiang W, Chung C, Grosshans D, Ballester L, Esquenazi Y, Kamiya-Matsuoka C, Yeboa DN. Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology. Journal of neuro-oncology 179(1), 2026. e-Pub 2026. PMID: 42489814.
      3. Ehret F, Horick NK, Yeap BY, Curry WT, Nahed B, Daartz J, Johnson JM, Dagher SA, Raza SM, DeMonte F, Yeboa DN, Swanson TA, McAleer MF, Leland P, McGovern SL, Shih HA. Dose Escalation With Intensity-Modulated Proton Therapy for Patients with High-Risk Meningiomas - Results From a Phase 1 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 32(16):3552-3560, 2026. e-Pub 2026. PMID: 42149137.
      4. Beckham, TH, Dudzinski, SO, Rooney, M, Faraj, CA, Pasli, M, Perni, S, Tom, MC, Ghia, AJ, Yeboa, DN, McAleer, MF, Swanson, T, McGovern, SL, Wang, C, Chung, C, De, BS, Jiang, W, Kim, BY, Ferguson, SD, Tawbi, H, Glitza, I, Le, X, Kaya, D, Dumbrava, EE, Briere, TM, Mackin, DS, Li, J. Incorporating an NCCN-Based Systemic Therapy CNS Activity Score Into SRS Decision-Making for Patients With 5 or More Brain Metastases. JNCCN Journal of the National Comprehensive Cancer Network 24(2):34-40, 2026. e-Pub 2026. PMID: 41671425.
      5. Yeboa, DN, Whitfield, BT, Lin, R, Ejezie, CL, Swanson, T, Beckham, TH, Wang, C, De, BS, Perni, S, Tom, MC, Li, J, McGovern, SL, Harrison, R, Majd, NK, Puduvalli, VK, Aaroe, AE, Loghin, ME, O'Brien, BJ, Patel, AD, Patel, C, Wefel, JS, Taslicay, CA, Gule-Monroe, MK, Paulino, AC, McAleer, MF, Grosshans, DR, Ghia, AJ, Jiang, W, Chung, C, Maor, MM, Yang, CH, Gubbiotti, M, Kamiya Matsuoka, C, Ballester, L, Weathers, S, Huse, J. Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses. Journal of neuro-oncology 176(1), 2026. e-Pub 2026. PMID: 41191157.
      6. Kleber, T, Milton, D, Srinivasan, S, Panthi, B, Floyd, W, Goethe, E, Davies, MA, Tawbi, H, Glitza, IC, Kaya, D, Li, J, Swanson, T, Perni, S, Tom, MC, Wang, C, Prabhu, SS, Weinberg, J, McCutcheon, IE, Chung, C, Ferguson, SD, Beckham, TH. Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgery. Neuro-Oncology Advances 8(1), 2026. e-Pub 2026. PMID: 41664820.
      7. Ding, Y, Salzillo, TC, Yeboa, DN, Tom, MC, Wang, Z, Diagaradjane, P, Subashi, ED, Yang, J, Swanson, T, Beckham, TH, Wang, C, Ghia, AJ, Briere, TM, Wang, J, Lathuilière, F, Cloake, S, Han, EY. Optimizing Motion Management and Baseline Shifts in Magnetic Resonance-Guided Spine Stereotactic Body Radiation Therapy. Cancers 17(16), 2025. e-Pub 2025. PMID: 40867326.
      8. Zhang, B, Shah, K, Parma, M, Wang, K, Singhi, EK, Lewis, WE, Rivera, MJ, Altan, M, Pozadzides, JV, Le, X, Vokes, N, Fossella, FV, O'Brien, BJ, Wang, C, Tom, MC, Beckham, TH, Swanson, T, Bronk, JK, Lin, SH, Vega, MF, Jacome, J, Halliday, A, Vailati Negrao, M, Zhang, J, Gibbons, DL, Heymach, JV, Byers, LA, Gay, CM. Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series. Journal of Thoracic Oncology 20(8):1131-1138, 2025. e-Pub 2025. PMID: 40126456.
      9. Yeboa, DN, Li, J, Lin, R, Prabhu, SS, Beckham, TH, Woodhouse, KD, Swanson, T, Weinberg, J, Wang, X, Chi, X, Ejezie, CL, Suki, D, Wang, C, Ene, CI, McCutcheon, IE, McGovern, SL, McAleer, MF, Tom, MC, Ghia, AJ, Perni, S, Jiang, W, De, BS, Chung, C, Kim, BY, O'Brien, BJ, Huse, J, Wefel, JS, Court, LE, Tawbi, H, Janku, F, Guha-Thakurta, N, Debnam, JM, Johnson, JM, Taslicay, CA, Alvarez-Breckenridge, C, Raza, SM, Heimberger, AB, DeMonte, F, North, RY, Briere, TM, de Groot, JF, Sawaya, RE, Grosshans, DR, Lang Jr, FF, Rao, G, Ferguson, SD. Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy. JAMA Oncology 11(8):890-899, 2025. e-Pub 2025. PMID: 40531511.
      10. Pham, L, Weller, L, Gann, CN, Schumacher, K, Vlassak, S, Swanson, T, Highsmith, KN, O’Brien, BJ, Nash, S, Aaroe, AE, De Groot, J, Majd, NK. Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion. Oncologist 30(1), 2025. e-Pub 2025. PMID: 38815166.
      11. Ene, CI, Abi Faraj, C, Beckham, TH, Weinberg, J, Andersen, C, Haider, A, Rao, G, Ferguson, SD, Alvarez-Brenkenridge, CA, Kim, BY, Heimberger, AB, McCutcheon, IE, Prabhu, SS, Wang, CM, Ghia, AJ, McGovern, SL, Chung, C, McAleer, MF, Tom, MC, Perni, S, Swanson, T, Yeboa, DN, Briere, TM, Huse, J, Fuller, GN, Lang Jr, FF, Li, J, Suki, D, Sawaya, RE. Response of treatment-naive brain metastases to stereotactic radiosurgery. Nature communications 15(1), 2024. e-Pub 2024. PMID: 38697991.
      12. Tom, MC, Komatineni, S, Wang, C, de Almeida, R, Ghia, AJ, Beckham, TH, Perni, S, McAleer, MF, Swanson, T, Yeboa, DN, De, BS, Rooney, MK, Bishop, AJ, Reddy, JP, Yang, Y, Ludmir, EB, Zhang, S, Amini, B, Alvarez-Breckenridge, C, North, RY, Rhines, LD, Li, J, Tatsui, CE. Spinal laser interstitial thermal therapy and radiotherapy for thoracic metastatic epidural spinal cord compression. Journal of neuro-oncology 170(2):289-296, 2024. e-Pub 2024. PMID: 39325339.
      13. Yadav D, Upadhyay R, Kumar VA, Chen MM, Johnson JM, Langshaw H, Curl BJ, Farhat M, Talpur W, Beckham TH, Yeboa DN, Swanson TA, Ghia AJ, Li J, Chung C. Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas. Pract Radiat Oncol 14(6):e449-e457, 2024. e-Pub 2024. PMID: 38685448.
      14. Beckham, TH, Rooney, MK, Cifter, G, Bernard, V, McAleer, MF, De, BS, Tom, MC, Perni, S, Wang, C, Swanson, T, Tatsui, CE, Alvarez-Breckenridge, C, North, RY, Rhines, LD, Tang, C, Logothetis, CJ, Amini, B, Li, J, Yeboa, DN, Ghia, AJ. Stereotactic radiosurgery for prostate cancer spine metastases. Journal of Neurosurgery: Spine 41(3):436-444, 2024. e-Pub 2024. PMID: 38875722.
      15. Beckham, TH, Rooney, MK, McAleer, MF, Ghia, AJ, Tom, MC, Perni, S, McGovern, SL, Grosshans, DR, Chung, C, Wang, C, De, BS, Swanson, T, Paulino, AC, Jiang, W, Ferguson, SD, Patel, C, Li, J, Yeboa, DN. Hypofractionated radiotherapy for glioblastoma. Neuro-Oncology Practice 11(3):266-274, 2024. e-Pub 2024. PMID: 38737610.
      16. Wang, C, Rooney, MK, Alvarez-Breckenridge, C, Beckham, TH, Chung, C, De, BS, Ghia, AJ, Grosshans, DR, Majd, NK, McAleer, MF, McGovern, SL, North, RY, Paulino, AC, Perni, S, Reddy, JP, Rhines, LD, Swanson, T, Tatsui, CE, Tom, MC, Yeboa, DN, Li, J. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era—A Population-Based Observational Study. Cancers 16(11), 2024. e-Pub 2024. PMID: 38893133.
      17. Beckham, TH, Dudzinski, SO, Pasli, M, Perni, S, Tom, MC, Ghia, AJ, Yeboa, DN, McAleer, MF, Swanson, T, McGovern, SL, Wang, C, Chung, C, Briere, TM, An, R, De, BS, Glitza, IC, Kim, YB, McCutcheon, IE, Ferguson, SD, Li, J. Radiosurgery to 5 or more newly diagnosed brain metastases in the systemic therapy era. Journal of Clinical Oncology 42(16):2026, 2024. e-Pub 2024.
      18. Garg AK, Hernandez M, Schlembach PJ, Bowers JR, McAleer MF, Brown PD, Gopal R, Wiederhold L, Swanson T, Shah SJ, Li J, Ferguson SD, Philip NV, DeGracia L, Bloom ES, Chun SG. A phase II clinical trial of frameless, fractionated stereotactic radiation therapy for brain metastases. JNCI Cancer Spectr 7(6), 2023. e-Pub 2023. PMID: 37944053.
      19. Garden AS, Harris J, Eisbruch A, Chao KSC, Morrison WH, Harari PM, Swanson TA, Jones CU, Yom SS, Spencer SA, Scrimger R, Shenouda G, Shukla M, Lau HY, Mierzwa M, Torres-Saavedra P, Le QT. Final Report of NRG Oncology RTOG 0022: A Phase I/II Study of Conformal and Intensity. Int J Radiat Oncol Biol Phys 117(2):333-340, 2023. e-Pub 2023. PMID: 36925074.
      20. Kharofa JR, Yothers G, Kachnic LA, Ajani J, Meyer JE, Augspurger ME, Okawara GS, Garg MK, Schefter TE, Swanson TA, Doncals DE, Kim H, Zaki BI, Narayan S, Lee RJ, Mamon HJ, Schwartz MA, Moughan J, Crane CH. Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529. Am J Clin Oncol 45(12):534-536, 2022. e-Pub 2022. PMID: 36413683.
      21. Quan E, Krafft SP, Briere TM, Vaccarelli MJ, Ghia AJ, Bishop AJ, Yeboa DN, Swanson TA, Han EY. Comparison of setup accuracy and efficiency between the Klarity system and BodyFIX system for spine stereotactic body radiation therapy. J Appl Clin Med Phys 23(11):e13804, 2022. e-Pub 2022. PMID: 36210179.
      22. Bahouth SM, Yeboa DN, Ghia AJ, Tatsui CE, Alvarez-Breckenridge CA, Beckham TH, Bishio AJ, Li J, McAleer MF, North RY, Rhines LD, Swanson TA, Chenyang W, Amini B. Multidisciplinary management of spinal metastases: what the radiologist needs to know. Br J Radiol 95(1138), 2022. e-Pub 2022. PMID: 35856792.
      23. Hasanov E, Yeboa DN, Tucker MD, Swanson TA, Beckham TH, Rini B, Ene CI, Hasanov M, Derks S, Smits M, Dudani S, Heng DYC, Brastianos PK, Bex A, Hanalioglu S, Weinberg JS, Hirsch L, Carlo MI, Aizer A, Brown PD, Bilen MA, Chang EL, Jaboin J, Brugarolas J, Choueiri TK, Atkins MB, McGregor BA, Halasz LM, Patel TR, Soltys SG, McDermott DF, Elder JB, Baskaya MK, Yu JB, Timmerman R, Kim MM, Mut M, Markert J, Beal K, Tannir NM, Samandouras G, Lang FF, Giles R, Jonasch E. An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma. CA Cancer J Clin 72(5):454-489, 2022. e-Pub 2022. PMID: 35708940.
      24. Golla V, Shan Y, Farran EJ, Stewart CA, Vu K, Yu A, Khaki AR, Parikh DA, Swanson TA, Keegan KA, Kamat AM, Tyler DS, Freedland SJ, Williams SB. Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer. Urol Oncol 40(6):273.e1-273.e9, 2022. e-Pub 2022. PMID: 35168881.
      25. Bagheri I, Shan Y, Klaasen Z, Kamat A, Konety B, Mehta H, Baillargeon J, Srinivas S, Tyler D, Swanson T, Kaul S, Hollenbeck B, Williams S. Comparing costs of radical versus partial cystectomy for patients diagnosed with localized muscle-invasive bladder cancer: understanding the value of surgical care. Urology 147:127-134, 2021. e-Pub 2021. PMID: 32980405.
      26. Lewis GD, Hatch SS, Wiederhold LR, Swanson TA. Long-term institutional experience with telemedicine services for Radiation Oncology: A potential model for long-term utilization. Adv Radiat Oncol 5(4):780-782, 2020. e-Pub 2020. PMID: 32391444.
      27. Williams SB, Shan Y, Ray-Zack MD, Hudgins HK, Jazzar U, Tyler DS, Freedland SJ, Swanson TA, Baillargeon JG, Hu JC, Kaul S, Kamat AM, Gore JL, Mehta HB. Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer. JAMA Surg, 2019. e-Pub 2019.
      28. Chevli N, Lewis GD, Swanson TA. The Use of "QUAD Shot" in Anal Canal Squamous Cell Carcinoma: A Case Study With Review of the Literature. J Pain Symptom Manage 57(2):341-345, 2019. e-Pub 2019.
      29. Williams SB, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Huo J, Senagore AJ, Orihuela E, Tyler DS, Swanson TA, Comparing KA. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer. JAMA Surg 153(10):881-889, 2018. e-Pub 2018.
      30. Chevli N, Lewis G, Swanson T. The use of "QUAD Shot" in anal canal squamous cell carcinoma: a case study with review of the literature. J Pain Symtom Manage 57(2):341-345, 2018. e-Pub 2018. PMID: 30403973.
      31. Stubbs, S, Vakil, H, Lewis, GD, Westergaard, SA, Campbell, GA, Swanson A, TA. Postoperative radiation for primary melanoma of the cervical spinal cord ina pregnant patient: A case report & review of the literature. Interdisciplinary Neurosurgery:139-141, 2018. e-Pub 2018.
      32. Williams S, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Hou J, Senagore, AJ, Tyler DS, Swanson TA, Kamat AM. Radical Cystectomy Provides Improved Survival Outcomes and Decreased Costs Compared With Trimodal Therapy for Patients Diagnosed With Localized Muscle-Invasive Bladder Cancer. JCO, 2017. e-Pub 2017.
      33. Tann AW, Hatch SS, Joyner MM, Wiederhold LR, Swansson TA. Accelerated partial breast irradiation: past, present, and future. World J Clin Oncol 7(5):370-379, 2016. e-Pub 2016. PMID: 27777879.
      34. Hatch SH, Mahmoud AE, John AC, Michael W, Melissa J, Swanson, T, Wiederhold, L. Pleomorphic Lobular Carcinoma of the Breast: A Review of 35 Cases at a Single Institution. Breast Can Curr Res 1(105), 2016. e-Pub 2016.
      35. Cox JA, Gajjar SR, Lanni TB, Swanson TA. Cost analysis of adjuvant management strategies in early-stage (stage I) testicular seminoma. Res Rep Urol 8(7):1-7, 2015. e-Pub 2015. PMID: 256108115.
      36. Cox JA, Sevak PR, Grumbles LL, Swanson TA, Hatch SS. Single-fraction radiotherapy for palliation of myelofibrosis-related extremity pain syndrome. J Pain Symptom Manage 48(2):299-304, 2014. e-Pub 2014. PMID: 24315514.
      37. Cox JA, Sevak PR, Sturgeon JD, Grumbles LL, Swanson TA, Hatch SS. Hypofractionated radiotherapy for palliation of myelofibrosis related lower extremity pain syndrome. J Pain Symptom Manage 48(2):299-304, 2014. e-Pub 2014.
      38. Swanson TA, Grills I, Ye H, Entwistle A, Teahan M, Letts N, Yan D, Duquette J, Vicini F. Six-Year Experience Routinely Utilizing Moderate Deep Inspiration Breath-hold (mDIBH) for the Reduction of Cardiac Dose in Left-Sided Breast Irradiation for Patients with Early Stage or Locally Advanced Breast Cancer. Am J Clin Oncol 36(1):24-30, 2013. e-Pub 2013.
      39. Swanson TA, Krueger SA, Galoforo S, Thibodeau BJ, Martinez AA, Wilson GW, Marples B. TMPRSS2/ERG Fusion Gene Expression alters Radio- and Chemo-Responsiveness in Cell Culture Models of Androgen Independent Prostate Cancer. The Prostate 71:1548-1558, 2011. e-Pub 2011.
      40. Kim SI, Myers M, Pabon A, Philibert KD, Wang M, Glucksman MJ. The role of neuropeptide processing enzymes in endocrine (prostate) cancer: EC3.4.24.15 (EP24.15). Protein Peptide Letters 11(5):471-478, 2004. e-Pub 2004.
      41. Swanson TA, Kim SI, Myers M, Pabon A, Philibert KD, Wang M, Glucksman MJ. M.J The role of neuropeptide processing enzymes in endocrine (prostate) cancer: EC3.4.24.15 (EP24.15). Protein Peptide letters 11(5):471-478, 2004. e-Pub 2004.
      42. Kim SW, Grant JE, Kim SI, Swanson TA, Bernstein GA, Jaszcz WB, Williams KA, Schlievert PM. A Possible Association of Recurrent Streptococcal Infections and Acute Onset of Obsessive-Compulsive Disorder 16:252-260, 2004. e-Pub 2004.
      43. Kim SI, Pabon AC, Swanson TA, Glucksman MJ. Regulation of Cell-Surface Major Histocompatibility Class I Expression by the Endopeptidase EP3.4.24.15 (Thimet 0ligopepitdase). Biochemical Journal 375:1-10, 2003. e-Pub 2003.
      44. Kim, SI, Grum-Tokars, V, Swanson, TA, Cotter, EJ, Cahill, PA, Roberts JL, Cummins PM, Glucksman MJ. Novel Roles of Neuropeptide Processing Enzymes: EC3.4.24.15. Neurome, Journal of Neuroscience Research 74:456-457, 2003. e-Pub 2003.
      45. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen BL, Melham G, Finley GG, Quike P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ. WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-l-transformed cells and aberrantly expressed in human colon tumors. Proceeding of the National Academy of Sciences 95:4717-4722, 1998. e-Pub 1998.
      46. Pennica D, Swanson TA, Shaw KJ, Kuang WJ, Gray C, Beatty BG, Wood WI. Human Cardiotrophin-1: Protein and Gene Structure, Biological and Binding Activities and Chromosomal Localization 8:183-189, 1996. e-Pub 1996.
      47. Pennica D, Arce, V, Swanson, TA, Vejsada, R, Pollock, RA, Arrnanini, M, Dudley, K, Phillips, HS, Rosenthal, A, Katp, A, Henderson, CE. Cardiotrophin-1, a Cytokine Present in Embryonic Muscle, Supports Long Time Survival of Spinal Motor Neurons. Neuron 17:63-74, 1996. e-Pub 1996.
      48. Jin H, Yang R, Keller G, Ryan A, Ko A, Finkle D, Swanson TA, Pennica D, Wood WI, Paoni NP. In Vivo Effects of Cardiotrophin-1. Cytokine 8:920-926, 1996. e-Pub 1996.
      49. Stone DM, Hynes M, Armanini M, Swanson TA, Gu Q, Johnson RL, Scott MP, Pennica D, Goddard A, Phillips H, Noll M, Hooper JE, de Sauvage F, Rosenthal A. Vertebrae Homologues of Patched and Smoothened Compose a Receptor for Sonic Hedgehog. Nature 384:129-134, 1996. e-Pub 1996.
      50. Pennica D, Shaw K, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF, Wood WI. Cardiotrophin-l: Biological Activities and Binding to the Leukemia Inhibitory Factor Receptor/gp130 Signaling Complex. Journal of Biological Chemistry 270:10915-10922, 1995. e-Pub 1995.

      Review Articles

      1. Bahouth SM, Yeboa DN, Ghia AJ, Tatsui CE, Alvarez-Breckenridge CA, Beckham TH, Bishop AJ, Li J, McAleer MF, North RY, Rhines LD, Swanson TA, Chenyang W, Amini B. Advances in the management of spinal metastases: what the radiologist needs to know. Br J Radiol 96(1141):20220267, 2023. e-Pub 2023. PMID: 35946551.

      Professional Educational Materials

      1. Swanson T, Kim S, Glucksman M. Biochemistry, Microbiology, and Genetics. Lippincott Williams & Wilkins, Board Review Series, 2009.
      2. Schneider A, Szanto P, Kim S, Swanson T. Pathology. Lippincott Williams & Wilkins, 2008.
      3. Kim S, Swanson T, Hussain N. Emergency Medicine. Lippincott Williams & Wilkins, 2007.
      4. Kim S, Swanson T. Pediatrics. Lippincott Williams & Wilkins, Underground Clinical Vignettes, 2007.
      5. Swanson T, Kim S, Kushen M. Pharmacology. Lippincott Williams & Wilkins, Underground Clinical Vignettes, 2007.
      6. Kim S, Swanson T. Psychiatry. Lippincott Williams & Wilkins, 2007.
      7. Kim S, Swanson T. Surgery. Lippincott Williams & Wilkins, 2007.
      8. Swanson T, Kim S, Hussain N. Underground Clinical Vignettes-Step 1. Lippincott Williams & Wilkins, 2007.
      9. Swanson T, Kim S, Kushen M. Anatomy. Lippincott Williams & Wilkins, 2007.
      10. Swanson T, Kim S, Glucksman M. Biochemistry. Lippincott Williams & Wilkins, 2007.
      11. Swanson T, Kim S, Flomin O. Immunology, Parasitology, Mycology. Lippincott Williams & Wilkins, 2007.
      12. Kim S, Swanson T. Internal Medicine 1: Cardiology, Endocrinology, Gastroenterology, Hematology/Oncology. Lippincott Williams & Wilkins, 2007.
      13. Kim S, Swanston T. Internal Medicine II: Dermatology Infectious Disease, Nephrology, Urology, Pulmonary, Rheumatology, Allergy. Lippincott Williams & Wilkins, 2007.
      14. Swanson T, Kim S, Flomin O. Microbiology II: Bacteriology, 2007.
      15. Kim S, Swanson T, Hussain N. Neurology. Lippincott Williams & Wilkins, 2007.
      16. Kim S, Swanson T. Obstetrics and Gynecology. Lippincott Williams & Wilkins, 2007.
      17. Swanson T, Kim S, Flomin O. Pathophysiology I: Pulmonary, Ob/Gyn, ENT, Hem/Onc. Lippincott Williams & Wilkins, 2007.
      18. Swanson T, Kim S, Flomin O. Pathophysiology II: GI, Neurology, Rheumatology, Endrocinology. Lippincott Williams & Wilkins, 2007.
      19. Swanson T, Kim S, Flomin O. Pathophysiology III. Lippincott Williams & Wilkins, 2007.
      20. Swanton T, Kim S, Glucksman M, Marks, D. Biochemistry and Molecular Biology. Lippincott Williams & Wilkins s, 2006.
      21. Swanson T, Kim S, Myers M. BRS Biochemistry Flashcards. Lippincott Williams & Wilkins, 2006.
      22. Schneider A, Szanto P, Kim S, Swanson T. Board Review Series. Lippincott Williams & Wilkins Board Review Series, 2005.
      23. Kim S, Swanson T. BRS Pharmacology Flashcards. Lippincott Williams & Wilkins Board Review Series, 2004.
      24. Swanson T, Kim S. BRS Anatomy Flashcards. 2.Swanson, T.A. and Kim, S.I. BRS Microbiology Flashcards. Lippincott Williams & Wilkins Board Review Series, 2003, 2004.
      25. Swanson T, Kim S. BRS Microbiology Flashcards. Lippincott Williams & Wilkins Board Review Series, 2003.
      26. Swanson T, Kim S. BRS Pathology Flashcards. Lippincott Williams & Wilkins Board Review Series, 2002.

      Editorials

      1. Tann AW, Hatch SS, Joyner MM, Wiederhold LW, Swanson TA. Accelerated Partial Breast Irradiation: Past, Present, and Future. World Journal of Clinical Oncology 7(5):370-379, 2016.
      2. Cox JA, Swanson TA. Current modalities of accelerated partial breast irradiation. Nature Reviews in Clinical Oncology 10(6):344-356, 2013.
      3. Swanson TA, Vicini FA. Overview of accelerated partial breast irradiation. Current Oncology Reports 10:54-60, 2008.
      4. Swanson TA, Vicini FA. Treatment Efficacy, Cosmesis, and Toxicity Using the Mammosite Breast Brachytherapy Applicator for the Delivery of Accelerated Partial Breast Irradiation. The American Journal of Hematology/Oncology 7(6):230-232, 2008.

      Abstracts

      1. Pham L, Gann C, Schumacher KM, Vlassak S, Swanson T, et al. Complete Response to Adjuvant Tepotinib in a Patient with Newly Diagnosed Disseminated Gliioblastoma (GBM) Harboring Met Amplification. Neuro-Oncology 23(6):vi109, 2021. e-Pub 2021.
      2. Williams S, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Hou J, Senagore AJ, Tyler DS, Swanson TA, Kamat AM. Radical Cystectomy Provides Improved Survival Outcomes and Decreased Costs Compared With Trimodal Therapy for Patients Diagnosed With Localized Muscle-Invasive Bladder Cancer. JCO, 2017. e-Pub 2017.
      3. Szeja S, Dandapani SV, Swanson TA. Impact of radiation and surgery for intraductal papillary neoplasm of the bile duct: A population-based analysis. J Clin Oncol, 2016. e-Pub 2016.
      4. Swanson TA, Veal S, Hatch S. Instituting Resident Evaluations Based on ACGME milestones vs. ACGME Core Competencies: A better yardstick, 2015. e-Pub 2015.
      5. Mayo LL, Cox JA, Endres EC, Sevak PR, Gajjar A, Sturgeon JA, Swanson TA. Management of synchronous primary rectal and prostate cancers: A case report and dosimetric comparison, 2014. e-Pub 2014.
      6. Cox JA, Sturgeon JD, Wolski MJ, Hatch SS, Swanson TA. An incoming resident mentoring initiative: Putting to practice the six ACGME core competencies for quality improvement and resident advancement, 2012. e-Pub 2012.
      7. Cox JA, Suri JS, Jana BRP, Orihuela E, Sturgeon JD, Endres EC, Colman M, Swanson TA. “Multimodality treatment of locally advanced penile cancer: A contemporary dosimetric comparison, 2012. e-Pub 2012.
      8. Sturgeon JD, Cox JA, Endres EC, Swanson TA. A comparison of VMAT, IMRT and four field technique for bone marrow preservation in post-operative cervical cancer, 2012. e-Pub 2012.
      9. Cox JA, Sevak PR, Sturgeon JD, Grumbles LL, Swanson TA, Hatch SS. “Hypofractionated radiotherapy for palliation of myelofibrosis related lower extremity pain syndrome”, 2012. e-Pub 2012.
      10. Cox JA, Sturgeon JD, Endres EC, Swanson TA, Wiederhold LR. Comparison of carotid sparing radiation treatment approaches for early laryngeal cancers: VMAT vs. IMRT”.ASTRO/ASCO Multidisciplinary Head and Neck Cancer Symposium, 2011. e-Pub 2011.
      11. Wolski MJ, Eldaya R, Swanson T, Sturgeon J, Wiederhold L, Colman M. Single Instituation Outcomes of Definitive Prostate Cancer Radiation Therapy with Favie Year Follow-up. American College of Radiation Oncology (ACRO) Annual Meeting, 2011. e-Pub 2011.
      12. Swanson, TA, Krueger S, Galoforo S, Thibodeau BJ, Martinez A, Grills IS, Wilson GD, Marples B. Effect of T2-ERG expression on chemo- and radioresponsiveness in prostate cancer, 2010. e-Pub 2010.
      13. Swanson TA, Krueger S, Galoforo S, Thibodeau BJ, Martinez A, Grills IS, Wilson GD, Marpels B. Effeto fo T2=ERG expression on chemo- and radioresponsiveness in prostate cancer. American Society for Clinical Oncology, Molecular Markers Symposium, 2010. e-Pub 2010.
      14. Swanson T, MartinA, Mohammed N, Wallace M, Maitz A, Chen P, Fontanessi J, Diaz F, Zamorano L, Grills I. Parameters Associated With Local Failures in Patients with Unresected Brain Metastasis Treated With Gamma Knife Radiosurgery, 2009. e-Pub 2009.
      15. Swanson T, Grills I, Wallace M, Ye H, Entwistle A, Teahan M, Letts N, Yan D, Duquette J, Vicini F. Six Year Experience Routinely Utilizing Moderate Deep Inspiration Breath-Hold (mDIBH) for the Reduction of Cardiac Dose in Left Sided Breast Irradiation for Patients with Early Stage or Locally Advanced Breast Cancer, 2009. e-Pub 2009.
      16. Goldstein, NS, Martinez A, Swanson T, Kestin L, Vicini, F. Clonality of Post- radiation, and Post-prostatectomy Adenocarcinomas: Some Local Recurrences are Second Primaries, 2008. e-Pub 2008.
      17. Swanson TA, Kim SI, Pabon A, Myers M, Philibert KD, Glucksman MJ. Proteomic Approaches to Identify Molecular Alterations in Androgen Independent Prostate Cancer and a Candidate Neuro-Endocrine Peptidase EP24.15, 2005. e-Pub 2005.
      18. Kim SI, Swanson TA, Glucksman, MJ. CCR5+ T Cells Regulate Type I Diabetes Development, 2003. e-Pub 2003.
      19. Kim SI, Swanson TA, Pabon A, Tullai JW, Glucksman MJ. Proteomics of neuropeptide processing enzymes as biomarkers in endocrine cancers, 2003. e-Pub 2003.
      20. Swanson TA, Kim S, Jun HS, Kim YB, Yoon JW. Suppressors of cytokine signaling differentially regulate antigen presentation in response to type I and type II interferons, 2003. e-Pub 2003.
      21. Swanson TA, Kim S. Suppressors of Cytokine Signaling (SOCS) Family Members Control Cytokine Production in NOD T Cells and May Have Implications for Autoimmune Diabetes in the Nonobese Diabetic (NOD) Mouse, 2003. e-Pub 2003.
      22. Swanson TA, Kim S, Jun HS, Kim YB, Yoon JW. Studies on the retroviral transduction efficiency in CD4+ T -cells using various T-cell stimulators, 2002. e-Pub 2002.
      23. Kim S, Swanson TA, Jun HS, Sun B, Kim YB, Yoon JW. The role of monocyte chemoattractant protein (MCP)-1 in T cell-mediated autoimmune diabetes in NOD mice, 2002. e-Pub 2002.

      Book Chapters

      1. Hendrickson, K, Swanson, T. The War on Cancer and Other Wars, 1965–1975, 111-124, 2026.
      2. Heard M, Thomas Jr CR, Swanson TA, Busch C. 125 Beams and the Rise of Radiation Therapy. Springer Cham, 2026.

      Books (edited and written)

      1. Swanson TA, Kim SI, Glucksman MJ. Biochemistry, Molecular Biology, and Genetics, 5th. ed,. Lippincott Williams & Wilkins Board Review Series, 2009.
      2. Schneider, AS, Szanto, PA, Kim, SI, Swanson A, TA:. Pathology, 4th. ed. Lippincott Williams & Wilkins, 2008.
      3. Swanson, TA, Kim, SI, Kushen, MC. Anatomy, 2007.
      4. Swanson, TA, Kim, SI, Hussain, NN. Underground Clinical Vignettes - Step I, 2007.
      5. Swanson, TA, Kim, SI, Glucksman, MJ. Biochemistry, 5th Edition, 2007.
      6. Swanson TA, Kim SI, Flomin OE. Pathophysiology I: Pulmonary, Ob/Gyn, ENT, Hem/Onc. Lippincott Williams & Wilkins, 2007.
      7. Swanson TA, Kim SI, Flomin OE. Pathophysiology II: GI, Neurology, Rheumatology, Endocrinology, 5th Edition. Lippincott Williams & Wilkins, 2007.
      8. Swanson, TA, Kim, SI, Flomin, OE. Pathophysiology III: 5th Edition. Lippincott Williams & Wilkins, Underground Clinical Vignettes, 2007.
      9. Swanson, TA, Kim, SI, Kushen, MC. Pharmacology, 5th Edition. Lippincott Williams & Wilkins, Underground Clinical Vignettes, 2007.
      10. Swanson, TA, Kim, SI, Flomin, OE. Immunology, Parasitology, Mycology, 5th Edition, 2007.
      11. Swanson, TA, Kim, SI, Flomin, OE:. Microbiology II: Bacteriology, 5th Edition. Lippincott, Williams & Wilkins, Underground Clinical Vignettes, 2007.
      12. Kim, SI, Swanson, TA, Hussain, NN. Emergency Medicine, 4th Edition, 2007.
      13. Kim, SI, Swanson, TA. Internal Medicine I: Cardiology, Endocrinology, Gastroenterology, Hematology/Oncology, 4th Edition. Lippincott Williams & Wilkins, Underground Clinical Vignettes - Step II, 2007.
      14. Kim, SI, Swanson, TA. Internal Medicine II: Internal Medicine II: Dermatology, Infectious Disease, Nephrology, Urology, Pulmonary, Rheumatology, Allergy. Lippincott Williams & Wilkins, Underground Clinical Vignettes, 2007.
      15. Kim, SI, Swanson, TA, Hussain, NN. Neurology, 4th Edition,. Lippincott Williams & Wilkins, Underground Clinical Vignettes, 2007.
      16. Kim, SI, Swanson, TA. Obstetrics and Gynecology, 4th Edition. Lippincott Williams & Wilkins, Underground Clinical Vignettes, 2007.
      17. Kim, SI, Swanson, TA. Pediatrics, 4th Edition. Lippincott Williams & Wilkins, Underground Clinical Vignettes, 2007.
      18. Kim, SI, Swanson, TA. Psychiatry, 4th. Lippincott Williams & Wilkins, 2007.
      19. Kim, SI, Swanson, TA. Surgery, 4th Edition. Lippincott Williams & Wilkins, Underground Clinical Vignettes, 2007.
      20. Swanson, TA, Kim, SI, Glucksman, MJ, Marks A, DB. Biochemistry and Molecular Biology, 4th. ed. Lippincott Williams & Wilkins Board Review Series, 2006.
      21. Swanson, TA, Kim, SI, Myers A, M. BRS Biochemistry Flashcards, 2006.
      22. Schneider, AS, Szanto, PA, Kim, SI, Swanson A, TA. Pathology, 3rd. ed, 2005.
      23. Swanson, TA, Kim, SI. BRS Anatomy Flashcards. Lippincott Williams & Wilkins Board Review Series, 2004.
      24. Kim, SI, Swanson, TA. BRS Pharmacology Flashcards, 2004.
      25. Swanson, TA, Kim, SI. BRS Microbiology Flashcards. Lippincott Williams & Wilkins Board Review Series, 2003.
      26. Swanson, TA, Kim, SI. BRS Pathology Flashcards. Lippincott Williams & Wilkins Board Review Series,, 2002.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 18, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top